Literature DB >> 20431421

Evaluation of the clinical significance of focal adhesion kinase and SRC expression in human pancreatic ductal adenocarcinoma.

Nikolaos A Chatzizacharias1, Constantinos Giaginis, Diamanto Zizi-Serbetzoglou, Gregory P Kouraklis, Gabriel Karatzas, Stamatios E Theocharis.   

Abstract

OBJECTIVES: Focal adhesion kinase (FAK) and Src, 2 protein tyrosine kinases, have been suggested to regulate several fundamental cellular activities that promote the malignant phenotype in various human tumors, including pancreatic adenocarcinoma. Even though research has already turned in laboratory investigations and clinical trials on the possible use of agents blocking the 2 enzymes in cancer management, the data on the clinical significance of FAK and Src in pancreatic adenocarcinoma are still scarce.
METHODS: The FAK and Src protein expression was assessed immunohistochemically in tumor specimens of 65 patients with pancreatic ductal adenocarcinoma and was statistically analyzed in relation to various clinicopathological characteristics, tumor proliferative capacity, and patients' survival.
RESULTS: The FAK expression correlated significantly with the T stage of the tumor (P = 0.037), whereas FAK staining intensity with patients' age (P = 0.030), tumors' histopathological grade of differentiation (P = 0.041), and M stage (P = 0.029). The Src expression correlated significantly with the stage of the tumor (P = 0.013) and patients' survival (log-rank test, P = 0.027), being also identified as an independent prognostic factor in multivariate analysis (P = 0.047). Furthermore, trends that did not reach statistical significance were noted between FAK and Src expression and staining intensity and several clinicopathological parameters.
CONCLUSIONS: The FAK and Src immunohistochemical expression was associated with certain clinicopathological parameters that are crucial for the patients' management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431421     DOI: 10.1097/MPA.0b013e3181d7abcc

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  14 in total

1.  Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry.

Authors:  Joao A Paulo; Linda S Lee; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Pancreas       Date:  2012-03       Impact factor: 3.327

2.  Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.

Authors:  Rony A François; Kyungah Maeng; Akbar Nawab; Frederic J Kaye; Steven N Hochwald; Maria Zajac-Kaye
Journal:  J Natl Cancer Inst       Date:  2015-05-12       Impact factor: 13.506

3.  Expression and clinical significance of FAK and Src proteins in human endometrial adenocarcinoma.

Authors:  Nikolaos A Chatzizacharias; Constantinos Giaginis; Elisavet Gatzidou; Gerasimos Tsourouflis; Ioannis Sfiniadakis; Paraskevi Alexandrou; Stamatios E Theocharis
Journal:  Pathol Oncol Res       Date:  2010-11-07       Impact factor: 3.201

4.  Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells.

Authors:  Divya Pathania; Yuting Kuang; Mario Sechi; Nouri Neamati
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

Review 5.  Systemic therapies for pancreatic cancer--the role of pharmacogenetics.

Authors:  Ross A Soo; Wei-Peng Yong; Federico Innocenti
Journal:  Curr Drug Targets       Date:  2012-06       Impact factor: 3.465

6.  FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Authors:  Stamatios Theocharis; Jerzy Klijanienko; Constantinos Giaginis; Paraskevi Alexandrou; Efstratios Patsouris; Xavier Sastre-Garau
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-10       Impact factor: 4.553

7.  Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation.

Authors:  Ho-Sung Lee; In-Hee Lee; Kyungrae Kang; Sang-In Park; Minho Jung; Seung Gu Yang; Tae-Wook Kwon; Dae-Yeon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-10       Impact factor: 2.650

Review 8.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

9.  Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patients.

Authors:  Teng Hou; Juan Xiao; Huiting Zhang; Haifeng Gu; Yanling Feng; Jundong Li
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

10.  Mechanistic evaluation of a novel small molecule targeting mitochondria in pancreatic cancer cells.

Authors:  Yumna H Shabaik; Melissa Millard; Nouri Neamati
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.